
Carmine Cuda
Examiner (ID: 8210)
| Most Active Art Unit | 3205 |
| Art Unit(s) | 3201, 3205, 2878 |
| Total Applications | 602 |
| Issued Applications | 542 |
| Pending Applications | 0 |
| Abandoned Applications | 60 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 5712158
[patent_doc_number] => 20060053504
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-03-09
[patent_title] => 'Tissue specific expression of exogenous proteins in transgenic chickens'
[patent_app_type] => utility
[patent_app_number] => 10/524089
[patent_app_country] => US
[patent_app_date] => 2003-08-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 26
[patent_figures_cnt] => 26
[patent_no_of_words] => 14646
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0053/20060053504.pdf
[firstpage_image] =>[orig_patent_app_number] => 10524089
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/524089 | Tissue specific expression of exogenous proteins in transgenic chickens | Aug 10, 2003 | Abandoned |
Array
(
[id] => 7183818
[patent_doc_number] => 20040203152
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-10-14
[patent_title] => 'Methods and compositions for genomic modification'
[patent_app_type] => new
[patent_app_number] => 10/636290
[patent_app_country] => US
[patent_app_date] => 2003-08-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 12
[patent_figures_cnt] => 12
[patent_no_of_words] => 23773
[patent_no_of_claims] => 23
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 3
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0203/20040203152.pdf
[firstpage_image] =>[orig_patent_app_number] => 10636290
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/636290 | Methods and compositions for genomic modification | Aug 4, 2003 | Issued |
Array
(
[id] => 7343433
[patent_doc_number] => 20040191800
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-09-30
[patent_title] => 'Uncoupling protein homologue: UCP3'
[patent_app_type] => new
[patent_app_number] => 10/627768
[patent_app_country] => US
[patent_app_date] => 2003-07-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5022
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 9
[patent_words_short_claim] => 18
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0191/20040191800.pdf
[firstpage_image] =>[orig_patent_app_number] => 10627768
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/627768 | Uncoupling protein homologue: UCP3 | Jul 24, 2003 | Abandoned |
Array
(
[id] => 7281545
[patent_doc_number] => 20040063922
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-04-01
[patent_title] => 'Methods and compositions for catalytic DNA exchange in a sequence specific manner'
[patent_app_type] => new
[patent_app_number] => 10/391415
[patent_app_country] => US
[patent_app_date] => 2003-07-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 12
[patent_figures_cnt] => 12
[patent_no_of_words] => 32827
[patent_no_of_claims] => 53
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 94
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0063/20040063922.pdf
[firstpage_image] =>[orig_patent_app_number] => 10391415
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/391415 | Methods and compositions for catalytic DNA exchange in a sequence specific manner | Jul 20, 2003 | Abandoned |
Array
(
[id] => 7178440
[patent_doc_number] => 20050124037
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-06-09
[patent_title] => 'Nucleic acid molecules encoding proteins which impart the adhesion of Neisseria cells to human cells'
[patent_app_type] => utility
[patent_app_number] => 10/617835
[patent_app_country] => US
[patent_app_date] => 2003-07-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 7994
[patent_no_of_claims] => 9
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0124/20050124037.pdf
[firstpage_image] =>[orig_patent_app_number] => 10617835
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/617835 | Nucleic acid molecules encoding proteins which impart the adhesion of Neisseria cells to human cells | Jul 13, 2003 | Abandoned |
Array
(
[id] => 7127266
[patent_doc_number] => 20050059010
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-03-17
[patent_title] => 'Macular degeneration diagnostics and therapeutics'
[patent_app_type] => utility
[patent_app_number] => 10/619761
[patent_app_country] => US
[patent_app_date] => 2003-07-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 12
[patent_figures_cnt] => 12
[patent_no_of_words] => 30718
[patent_no_of_claims] => 52
[patent_no_of_ind_claims] => 7
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0059/20050059010.pdf
[firstpage_image] =>[orig_patent_app_number] => 10619761
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/619761 | Macular degeneration diagnostics and therapeutics | Jul 13, 2003 | Abandoned |
Array
(
[id] => 7216658
[patent_doc_number] => 20040088746
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-05-06
[patent_title] => 'Apoptosis-inducing dna sequences'
[patent_app_type] => new
[patent_app_number] => 10/332859
[patent_app_country] => US
[patent_app_date] => 2003-06-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 20515
[patent_no_of_claims] => 25
[patent_no_of_ind_claims] => 7
[patent_words_short_claim] => 23
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0088/20040088746.pdf
[firstpage_image] =>[orig_patent_app_number] => 10332859
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/332859 | Apoptosis-inducing dna sequences | Jun 24, 2003 | Abandoned |
Array
(
[id] => 698504
[patent_doc_number] => 07067281
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2006-06-27
[patent_title] => 'Mammalian IAP gene family, primers, probes and detection methods'
[patent_app_type] => utility
[patent_app_number] => 10/600272
[patent_app_country] => US
[patent_app_date] => 2003-06-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 61
[patent_figures_cnt] => 75
[patent_no_of_words] => 17369
[patent_no_of_claims] => 9
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 35
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/067/07067281.pdf
[firstpage_image] =>[orig_patent_app_number] => 10600272
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/600272 | Mammalian IAP gene family, primers, probes and detection methods | Jun 19, 2003 | Issued |
Array
(
[id] => 6958575
[patent_doc_number] => 20050214945
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-09-29
[patent_title] => 'Htlv-I tax induced killing of p53 null cancer cells'
[patent_app_type] => utility
[patent_app_number] => 10/514475
[patent_app_country] => US
[patent_app_date] => 2003-05-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 8
[patent_no_of_words] => 10262
[patent_no_of_claims] => 44
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0214/20050214945.pdf
[firstpage_image] =>[orig_patent_app_number] => 10514475
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/514475 | Htlv-I tax induced killing of p53 null cancer cells | May 15, 2003 | Abandoned |
Array
(
[id] => 662481
[patent_doc_number] => 07101689
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2006-09-05
[patent_title] => 'Interleukin-18 binding proteins, their preparation and use'
[patent_app_type] => utility
[patent_app_number] => 10/434583
[patent_app_country] => US
[patent_app_date] => 2003-05-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 25
[patent_figures_cnt] => 25
[patent_no_of_words] => 17952
[patent_no_of_claims] => 13
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 14
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/101/07101689.pdf
[firstpage_image] =>[orig_patent_app_number] => 10434583
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/434583 | Interleukin-18 binding proteins, their preparation and use | May 7, 2003 | Issued |
Array
(
[id] => 1014500
[patent_doc_number] => 06893842
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2005-05-17
[patent_title] => 'T-type calcium channel variants; compositions thereof; and uses'
[patent_app_type] => utility
[patent_app_number] => 10/425800
[patent_app_country] => US
[patent_app_date] => 2003-04-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 10
[patent_figures_cnt] => 10
[patent_no_of_words] => 15603
[patent_no_of_claims] => 7
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 27
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/893/06893842.pdf
[firstpage_image] =>[orig_patent_app_number] => 10425800
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/425800 | T-type calcium channel variants; compositions thereof; and uses | Apr 28, 2003 | Issued |
Array
(
[id] => 6769483
[patent_doc_number] => 20030215423
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-11-20
[patent_title] => 'Gene therapy for obesity'
[patent_app_type] => new
[patent_app_number] => 10/419549
[patent_app_country] => US
[patent_app_date] => 2003-04-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 43
[patent_figures_cnt] => 43
[patent_no_of_words] => 11467
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 14
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0215/20030215423.pdf
[firstpage_image] =>[orig_patent_app_number] => 10419549
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/419549 | Gene therapy for obesity | Apr 20, 2003 | Abandoned |
Array
(
[id] => 7219348
[patent_doc_number] => 20050260579
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-11-24
[patent_title] => 'TGF-beta type receptor cDNAs encoded products'
[patent_app_type] => utility
[patent_app_number] => 10/420192
[patent_app_country] => US
[patent_app_date] => 2003-04-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 9655
[patent_no_of_claims] => 7
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0260/20050260579.pdf
[firstpage_image] =>[orig_patent_app_number] => 10420192
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/420192 | TGF-beta type receptor cDNAs encoded products | Apr 17, 2003 | Abandoned |
Array
(
[id] => 6823042
[patent_doc_number] => 20030221203
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-11-27
[patent_title] => 'High efficiency regulatable gene expression system'
[patent_app_type] => new
[patent_app_number] => 10/148521
[patent_app_country] => US
[patent_app_date] => 2003-04-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 12198
[patent_no_of_claims] => 43
[patent_no_of_ind_claims] => 10
[patent_words_short_claim] => 24
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0221/20030221203.pdf
[firstpage_image] =>[orig_patent_app_number] => 10148521
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/148521 | High efficiency regulatable gene expression system | Apr 3, 2003 | Abandoned |
Array
(
[id] => 6664160
[patent_doc_number] => 20030203486
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-10-30
[patent_title] => 'Transfection method and uses related thereto'
[patent_app_type] => new
[patent_app_number] => 10/403720
[patent_app_country] => US
[patent_app_date] => 2003-03-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 7
[patent_no_of_words] => 23738
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 67
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0203/20030203486.pdf
[firstpage_image] =>[orig_patent_app_number] => 10403720
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/403720 | Transfection method and uses related thereto | Mar 27, 2003 | Abandoned |
Array
(
[id] => 6678460
[patent_doc_number] => 20030228601
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-12-11
[patent_title] => 'Transfection method and uses related thereto'
[patent_app_type] => new
[patent_app_number] => 10/403630
[patent_app_country] => US
[patent_app_date] => 2003-03-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 7
[patent_no_of_words] => 23724
[patent_no_of_claims] => 17
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 132
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0228/20030228601.pdf
[firstpage_image] =>[orig_patent_app_number] => 10403630
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/403630 | Transfection method and uses related thereto | Mar 27, 2003 | Abandoned |
Array
(
[id] => 7133463
[patent_doc_number] => 20040043010
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-03-04
[patent_title] => 'Delivery of bioactive compounds to an organism'
[patent_app_type] => new
[patent_app_number] => 10/393143
[patent_app_country] => US
[patent_app_date] => 2003-03-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 26
[patent_figures_cnt] => 26
[patent_no_of_words] => 36209
[patent_no_of_claims] => 5
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 79
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0043/20040043010.pdf
[firstpage_image] =>[orig_patent_app_number] => 10393143
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/393143 | Delivery of bioactive compounds to an organism | Mar 19, 2003 | Abandoned |
Array
(
[id] => 7216581
[patent_doc_number] => 20050260178
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-11-24
[patent_title] => 'Delivery of an organized tissue to an organism'
[patent_app_type] => utility
[patent_app_number] => 10/392500
[patent_app_country] => US
[patent_app_date] => 2003-03-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 9378
[patent_no_of_claims] => 52
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0260/20050260178.pdf
[firstpage_image] =>[orig_patent_app_number] => 10392500
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/392500 | Delivery of an organized tissue to an organism | Mar 19, 2003 | Abandoned |
Array
(
[id] => 6806275
[patent_doc_number] => 20030233669
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-12-18
[patent_title] => 'Perlecan transgenic animals and methods of identifying compounds for the treatment of amyloidoses'
[patent_app_type] => new
[patent_app_number] => 10/384172
[patent_app_country] => US
[patent_app_date] => 2003-03-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 25
[patent_figures_cnt] => 25
[patent_no_of_words] => 25556
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 8
[patent_words_short_claim] => 15
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0233/20030233669.pdf
[firstpage_image] =>[orig_patent_app_number] => 10384172
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/384172 | Perlecan transgenic animals and methods of identifying compounds for the treatment of amyloidoses | Mar 4, 2003 | Abandoned |
Array
(
[id] => 6866541
[patent_doc_number] => 20030192067
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-10-09
[patent_title] => 'Delivery system'
[patent_app_type] => new
[patent_app_number] => 10/375050
[patent_app_country] => US
[patent_app_date] => 2003-02-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 8838
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 10
[patent_words_short_claim] => 22
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0192/20030192067.pdf
[firstpage_image] =>[orig_patent_app_number] => 10375050
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/375050 | Delivery system | Feb 27, 2003 | Abandoned |